Candriam SCA’s STAAR Surgical STAA Stock Holding History

Candriam SCA’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-39,000	Closed	-$1.34M	–	866
2020 Q1	$1.34M	Hold	39,000	–	–	0.01%	602
2019 Q4	$1.37M	Hold	39,000	–	–	0.01%	618
2019 Q3	$1M	Hold	39,000	–	–	0.01%	607
2019 Q2	$1.14M	Hold	39,000	–	–	0.01%	630
2019 Q1	$1.33M	Hold	39,000	–	–	0.02%	573
2018 Q4	$1.24M	Sell	39,000 -11,000	-22%	-$429K	0.02%	547
2018 Q3	$2.4M	Sell	50,000 -35,000	-41%	-$1.43M	0.03%	463
2018 Q2	$2.63M	Sell	85,000 -28,000	-25%	-$655K	0.04%	425
2018 Q1	$1.67M	Hold	113,000	–	–	0.03%	510
2017 Q4	$1.75M	Hold	113,000	–	–	0.03%	482
2017 Q3	$1.41M	Hold	113,000	–	–	0.02%	515
2017 Q2	$1.22M	Buy	113,000 +68,000	+151%	+$665K	0.02%	546
2017 Q1	$441K	Buy	+45,000	New	+$449K	0.01%	653

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Candriam SCA's STAA Position: Q2 2020 in Review

Candriam SCA sold out of STAAR Surgical (STAA) in Q2 2020, closing a stake of 39,000 shares — an estimated $1.34M sold.

Candriam SCA first reported a position in STAA in Q1 2017 and held it in 13 quarters. The position peaked at $2.63M in Q2 2018. 192 funds tracked by Wall St. Rank hold STAA as of Q2 2020.

Candriam SCA reported no remaining STAAR Surgical position as of Q2 2020 after selling out during the quarter.
Candriam SCA sold 39,000 STAAR Surgical shares in Q2 2020, an estimated $1.34M.
Candriam SCA first reported a position in STAAR Surgical in Q1 2017 and held it in 13 quarters.
Candriam SCA's STAAR Surgical position peaked at $2.63M in Q2 2018.
192 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2020.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.